PK-PD Modelling and Analytics

Optimise Drug Development Decisions Through Modelling

Model Answers helps to take the risk out of drug development decisions by using its in-built knowledge, experience, and data analysis techniques to improve the understanding and decision making at every stage of development.

Are there covariates that can explain variability in PK or PD response?
Optimising dose selection: Balancing the risk/benefit profile

Exploratory Modelling

Our PK-PD modelling and simulation can be used to explore the “what if” scenarios before designing your trials, which ensures that you can maximise the use of your resources and increase the probability of a successful trial outcome.

Modelling and Non-Compartmental Analysis

In supporting development programs we analyse the available PK or PK-PD data using either model based techniques and/or non-compartmental based approaches. If you are not familiar with model-based techniques, see this great introductory video from our colleagues at Roche.

Contact Us to find out how Model Answers can help you plan the optimal use of PK-PD analysis, modelling and simulation in the drug development life cycle.